Posted on September 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on August 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on July 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on July 3, 20247/3/24
Transforming the Future of Pharma Commercialization Through Medical Affairs
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on June 21, 20246/21/24
Optimizing Product Commercialization in Today’s IDN Environment
Posted on June 5, 20246/5/24
FDA Guidance and Considerations for Scientific Exchange Communication Strategies
Posted on May 23, 20245/23/24
Bridging “Share of Voice” with “Share of Influence” for Lasting Impact
Posted on May 23, 20245/23/24